Amlodipine And Valsartan Tablet
Product Images NDC 43386-080

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 43386-080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bdf7450f 3512 4635 8180 8bcdd09edc16 01

Two side-by-side graphs showing the probability of achieving target blood pressure levels at Week 8 for amlodipine and valsartan 10 mg/320 mg tablets compared to valsartan 320 mg, amlodipine 10 mg, and placebo. The left graph depicts systolic blood pressure under 140 mmHg versus baseline SBP, while the right graph shows diastolic blood pressure under 90 mmHg versus baseline DBP.*

FDA Label Image

Bdf7450f 3512 4635 8180 8bcdd09edc16 02

Two graphs depict the probability of achieving blood pressure targets with various treatments. The left graph shows probability versus baseline systolic blood pressure (SBP) for systolic BP <130 mmHg at week 8. The right graph shows probability versus baseline diastolic blood pressure (DBP) for diastolic BP <80 mmHg at week 8. Treatment groups include amlodipine and valsartan tablets 10 mg/320 mg, valsartan 320 mg, amlodipine 10 mg, and placebo.*

FDA Label Image

Bdf7450f 3512 4635 8180 8bcdd09edc16 03

Chemical structure of the active ingredient amlodipine as shown in the image. The diagram includes aromatic rings and functional groups typical of amlodipine's molecular structure, including chlorine and ester groups.*

FDA Label Image

Bdf7450f 3512 4635 8180 8bcdd09edc16 04

Chemical structure of valsartan, one of the active ingredients in the drug amlodipine and valsartan. The structure shows the detailed arrangement of atoms and bonds within the valsartan molecule.*

FDA Label Image

Bdf7450f 3512 4635 8180 8bcdd09edc16 05

A rectangular pharmaceutical label for Amlodipine and Valsartan tablets, 5 mg/160 mg strength, from Lupin Pharmaceuticals, Inc. The label indicates the product is prescription only, comes in a 30-tablet package, and includes dosage details. The label also provides storage instructions and manufacturer information for Novel Laboratories, Inc. and GAVIS Pharmaceuticals, LLC.*

FDA Label Image

Bdf7450f 3512 4635 8180 8bcdd09edc16 06

Packaging label for Amlodipine and Valsartan tablets 10 mg/160 mg by Lupin Pharmaceuticals, Inc. The label indicates 90 tablets per package and lists the active ingredients with their amounts: 13.9 mg amlodipine besylate (equivalent to 10 mg amlodipine) and 160 mg valsartan. Includes storage instructions and manufacturer information for Gavis Pharmaceuticals, LLC.*

FDA Label Image

Bdf7450f 3512 4635 8180 8bcdd09edc16 07

A rectangular label for Amlodipine and Valsartan tablets, 5 mg/320 mg, from GAVIS Pharmaceuticals. The label shows the product name, strength, and dosage form (tablets) for oral use. It indicates 30 tablets per package and displays active ingredient amounts per tablet: 6.9 mg amlodipine besylate equivalent to 5 mg amlodipine and 320 mg valsartan. Additional information includes storage instructions, manufacturing details by Novel Laboratories, Inc. and GAVIS Pharmaceuticals, and a barcode.*

FDA Label Image

Bdf7450f 3512 4635 8180 8bcdd09edc16 08

Label for Amlodipine and Valsartan tablets, 10 mg/320 mg strength, by Lupin Pharmaceuticals, Inc. The label shows the product name prominently, dosage form as tablets, package size of 90 tablets, and includes active ingredient amounts. It also lists storage instructions, manufacturer details, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.